Global Infectious Disease Molecular Diagnostics Market Forecast to Reach $36.98 Billion by 2029, Driven by 5% CAGR
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Industry Valuation for the Infectious Disease Molecular Diagnostics Sector?
In recent years, the molecular diagnostics market for infectious diseases has experienced significant growth. The market is projected to expand from $28.95 billion in 2024 to $30.46 billion in 2025, representing a compound annual growth rate (CAGR) of 5.2%. The historic growth of this market can be traced back to factors such as the higher occurrence of infectious diseases, growing need for swift and precise diagnosis, an upsurge in worldwide epidemics and pandemics, enhanced healthcare consciousness and accessibility, and an increase in funding for diagnostic research and technology.
The market size for molecular diagnostics in infectious diseases is projected to exhibit robust growth in the upcoming years. The expectation is an expansion to $36.98 billion by the year 2029, leveraging a compound annual growth rate (CAGR) of 5.0%. This growth during the forecast period can be credited to the increased adoption of point-of-care testing, an intensified emphasis on personalized medicine, escalating governmental backing for infectious disease management, the augmentation of healthcare infrastructure in developing markets, and the escalating incidences of respiratory diseases. The trends to watch out for in the forecast period include technological advancements in real-time polymerase chain reaction, significant integration of artificial intelligence into diagnostic platforms, development of multiplex testing panels, innovation in portable and home-based diagnostic kits, and evolution in automation of molecular diagnostic processes.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp
What Forces Are Driving The Growth Of The Infectious Disease Molecular Diagnostics Market?
The growing incidence of infectious diseases is likely to drive the expansion of the infectious disease molecular diagnostics market. These diseases, which are caused by harmful microorganisms including bacteria, viruses, fungi, or parasites, can be transmitted either directly or indirectly between individuals. The surge in infectious diseases can be attributed mainly to globalisation and extensive travel, leading the pathogens to quickly cross borders and convert localised outbreaks into international health crises. Infectious disease molecular diagnostics aid disease management by accurately and swiftly detecting pathogens at a genetic level. This accelerates early diagnosis and specific treatment which optimises outbreak control. For instance, the United States documentated 8,331 tuberculosis cases in 2022, a 5.9% increase from 2021, as stated by the Centers for Disease Control and Prevention, a government in the US, in November 2023. Hence, the escalation of infectious diseases is stimulating the growth of the infectious disease molecular diagnostics market.
How Is The Infectious Disease Molecular Diagnostics Industry Segmented Across Key Parameters?
The infectious disease molecular diagnostics market covered in this report is segmented –
1) By Product Type: Kits And Reagents, Instruments, Software And Services
2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Mass Spectrometry, Transcription Mediated Amplification, Other Technologies
3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications
4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes
Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits
2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers
3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services
What Notable Trends Are Shaping The Direction Of The Infectious Disease Molecular Diagnostics Market?
Leading firms in the infectious disease molecular diagnostics market are striving to create cutting-edge solutions like real-time polymerase chain reaction kits. These kits serve as diagnostic instruments that amplify and simultaneously identify specific genetic materials of pathogens in ‘real time’. This paves the way for quick and precise identification of infectious diseases. For example, Thermo Fisher Scientific Inc., an American-based biotech and life science organization, introduced Applied Biosystems TaqPath polymerase chain reaction kits in India in February 2023. These kits, explicitly engineered for infectious disease detection, are fast, extremely sensitive multiplex diagnostic tools that facilitate real-time polymerase chain reaction identification of infectious disease targets. They carry out the spectrum of processes from ribonucleic acid extraction to diagnostic report formation, typically in under 4 hours. These kits incorporate multiplexed assays targeting diverse genomic areas of pathogens, include internal process controls, and provide automated data interpretation. This diminishes user error and elevates the reliability of the results.
Which Companies Currently Dominate The Competitive Landscape In The Infectious Disease Molecular Diagnostics Industry?
Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.
Get The Full Report Here:
Which Geographic Regions Are Driving Demand In The Infectious Disease Molecular Diagnostics Market?
North America was the largest region in the infectious disease molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=25793&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
